List view / Grid view
Almac Group, the Craigavon based global contract pharmaceutical development and manufacturing organisation, is pleased to announce the successful inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) of its new Pharmaceutical Development & Manufacturing facilities at Charnwood Campus, Loughborough...
Study examines potential of scalpel-free surgery to manage tremor...
Researchers have designed synthetic beta cells that secrete insulin in response to high blood sugar...
The FDA has approved the 10 mg once-daily dose of Xarelto, for reducing the continued risk of recurrent venous thromboembolism...
Crisaborole and dupilumab approved for atopic dermatitis…
Universal Influenza Vaccine Initiative will address the underlying scientific barrier impeding the development of broadly protective, universal influenza vaccines...
Sandoz has announced that its biosimilar pegfilgrastim has been accepted by the EMA for regulatory review...
Scientists have found that some potential γ-secretase inhibitors such as semagacestat, do not function as true inhibitors as originally expected...
FDA collaboration will characterise the performance of Organs-on-Chips as a platform for potential use in drug development and regulatory evaluation...
Researchers have proposed a unique way to reach the concentration of anti-EGFR drug needed to fight exon 20 insertions without harming healthy tissues...
With ongoing and ever tightened budget cuts, pharma companies are struggling to prioritise projects with limited R&D budget – whilst at the same time the patent cliff is drying up the product pipeline which will have immense aftermaths of the company’s revenue stream...
Blood-thinning drugs not only reduce the risk of stroke in patients with AF but are also associated with a significant reduction in the risk of dementia...
Proton beam therapy, in combination with chemotherapy, may be a better treatment option than traditional radiation therapy techniques...
Epigenetic data reveals immune-response pathways that may prove critical to understanding autism...
Researchers have found a way of reducing the treatment required for lymphatic filariasis and onchocerciasis from several weeks to seven days...
